Mostrar el registro sencillo del ítem
Predicting Human miRNA-like Sequences within Human Papillomavirus Genomes
dc.contributor.author | Gutierrez, DA | |
dc.date.accessioned | 2019-01-19T17:38:44Z | |
dc.date.available | 2019-01-19T17:38:44Z | |
dc.date.issued | 2018-07 | |
dc.identifier.uri | http://cathi.uacj.mx/20.500.11961/7036 | |
dc.description.abstract | BACKGROUND: This study presents a prediction of putative miRNA within several Human Papillomavirus (HPV) types by using bioinformatics tools and a strategy based on sequence and structure alignment. Currently, little is known about HPV miRNAs. METHODS: Computational methods have been widely applied in the identification of novel miRNAs when analyzing genome sequences. Here, ten whole-genome sequences from HPV-6, -11, -16, -18, -31, -33, -35, -45, -52, and -58 were analyzed. Software based on local contiguous structure-sequence features and support vector machine (SVM), as well as additional bioinformatics tools, were utilized for identification and classification of real and pseudo microRNA precursors. RESULTS: An initial analysis predicted 200 putative pre-miRNAs for all the ten HPV genome variants. To derive a smaller set of pre-miRNAs candidates, stringent validation criteria was conducted by applying <‒10 ΔG value (Gibbs Free Energy). Thus, only pre-miRNAs with total scores above the cut-off points of 90% were considered as putative pre-miRNAs. As a result of this strategy, 19 pre-miRNAs were selected (hpv-pre-miRNAs). These novel pre-miRNAs were located in different clusters within HPV genomes and some of them were positioned at splice regions. Additionally, the 19 identified pre-miRNAs sequences varied between HPV genotypes. Interestingly, the newly identified miRNAs, 297, 27b, 500, 501-5, and 509-3-5p, were closely implicated in carcinogenesis participating in cellular longevity, cell cycle, metastasis, apoptosis evasion, tissue invasion and cellular growth pathways. CONCLUSIONS: The novel putative miRNAs candidates could be promising biomarkers of HPV infection and furthermore, could be targeted for potential therapeutic interventions in HPV-induced malignancies. | es_MX |
dc.description.uri | https://www.ncbi.nlm.nih.gov/pubmed/30401587 | es_MX |
dc.language.iso | en_US | es_MX |
dc.relation.ispartof | Producto de investigación ICB | es_MX |
dc.relation.ispartof | Instituto de Ciencias Biomédicas | es_MX |
dc.subject | apoptosis | es_MX |
dc.subject | bioinformatics | es_MX |
dc.subject | Cancinogenesis | es_MX |
dc.subject | Pre:miRNA | es_MX |
dc.subject.other | info:eu-repo/classification/cti/6 | es_MX |
dc.title | Predicting Human miRNA-like Sequences within Human Papillomavirus Genomes | es_MX |
dc.type | Artículo | es_MX |
dcterms.thumbnail | http://ri.uacj.mx/vufind/thumbnails/rupiicb.png | es_MX |
dcrupi.instituto | Instituto de Ciencias Biomédicas | es_MX |
dcrupi.cosechable | Si | es_MX |
dcrupi.norevista | 49 | es_MX |
dcrupi.volumen | 5 | es_MX |
dcrupi.nopagina | 323-334 | es_MX |
dc.identifier.doi | 10.1016/j.arcmed.2018.10.008. Epub 2018 Nov | es_MX |
dc.contributor.coauthor | Varela Ramirez, A | |
dc.contributor.coauthor | Rodriguez Esquivel, M | |
dc.contributor.coauthor | Mendoza Rodriguez, MG | |
dc.contributor.coauthor | Ayala Sumuano, JC | |
dc.contributor.coauthor | Pineda, D | |
dc.contributor.coauthor | Garrido Guerrero, E | |
dc.contributor.coauthor | Jimenez Vega, F | |
dc.contributor.coauthor | Aguilar, S | |
dc.contributor.coauthor | Quiñones, M | |
dc.contributor.coauthor | Nambo, MJ | |
dc.contributor.coauthor | Chavez Olmos, P | |
dc.contributor.coauthor | Taniguci Ponciano, K | |
dc.contributor.coauthor | Marrero Rodriguez, D | |
dc.contributor.coauthor | Romero Morelos, P | |
dc.contributor.coauthor | Castro, JP | |
dc.contributor.coauthor | Bandala, C | |
dc.contributor.coauthor | Carrillo Romero, A | |
dc.contributor.coauthor | Gonzalez Yebra, B | |
dc.contributor.coauthor | Salcedo, M | |
dc.journal.title | Archives of Medical Research | es_MX |
dc.lgac | Genómica Funcional | es_MX |
dc.cuerpoacademico | Ingeniería Tisular y Medicina Regenerativa | es_MX |